Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
16:00:03 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 92.01 USD | -2.57% |
|
+3.30% | +7.93% |
| Market Cap | 53.03B 47.5B 43.69B 39.59B 74B 5,036B 75.38B 521B 209B 2,649B 199B 195B 8,354B | P/E 2026 * |
36.5x | P/E 2027 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 49.4B 44.25B 40.7B 36.88B 68.93B 4,691B 70.22B 485B 195B 2,468B 185B 181B 7,782B | EV / Sales 2026 * |
7.31x | EV / Sales 2027 * | 6.44x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Tradegate
| EWL | Real-time | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -2.57% | ||
| 1 week | +3.30% | ||
| 1 month | +8.01% | ||
| 3 months | +6.90% | ||
| 6 months | +9.56% | ||
| Current year | +7.93% |
| 1 week | 89.73 |  | 95.34 |
| 1 month | 82.42 | | 95.34 |
| Current year | 74.66 | | 96.29 |
| 1 year | 74.66 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 9/14/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.57% | +3.30% | +11.59% | +44.15% | 53.03B | |
| -1.72% | +3.44% | +22.84% | +58.01% | 258B | |
| -2.00% | +0.75% | +7.82% | +22.23% | 163B | |
| -3.73% | -4.48% | -19.14% | +59.73% | 150B | |
| -1.66% | -8.12% | -58.32% | -18.74% | 60.84B | |
| +0.93% | +2.29% | -11.39% | -8.71% | 53.31B | |
| +0.84% | -3.12% | +7.47% | +67.31% | 50.67B | |
| -3.47% | +1.04% | +19.48% | +70.01% | 49.3B | |
| -3.61% | +1.99% | +32.36% | +92.13% | 45.46B | |
| -18.64% | -12.41% | +91.02% | +121.25% | 35.68B | |
| Average | -1.14% | -1.51% | +10.37% | +50.74% | 91.97B | |
| Weighted average by Cap. | -0.64% | -0.33% | +7.42% | +47.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.06B 5.57B 5.05B 9.43B 642B 9.61B 66.42B 26.66B 338B 25.37B 24.83B 1,065B | 7.43B 6.66B 6.12B 5.55B 10.37B 706B 10.56B 73B 29.31B 371B 27.89B 27.29B 1,170B |
| Net income | 1.46B 1.31B 1.2B 1.09B 2.03B 138B 2.07B 14.33B 5.75B 72.84B 5.47B 5.36B 230B | 1.88B 1.69B 1.55B 1.4B 2.63B 179B 2.67B 18.49B 7.42B 93.99B 7.06B 6.91B 296B |
| Net Debt | -3.63B -3.25B -2.99B -2.71B -5.07B -345B -5.16B -35.67B -14.32B -181B -13.63B -13.34B -572B | -5.19B -4.65B -4.28B -3.88B -7.25B -493B -7.38B -51.03B -20.49B -259B -19.5B -19.08B -818B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$92.01 | -2.57% | 6,044,702 |
| 26-10-29 | US$94.44 | +2.90% | 4,680,786 |
| 26-10-28 | US$91.78 | +1.06% | 2,296,758 |
| 26-10-27 | US$90.82 | +0.29% | 3,020,207 |
| 26-10-26 | US$90.56 | +1.67% | 3,326,977 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
